Report for: Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial

Title	Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial
Published in	Trials, January 2021
DOI	10.1186/s13063-020-04998-5
Pubmed ID	33430924
Authors	W. Dioh, M. Chabane, C. Tourette, A. Azbekyan, C. Morelot-Panzini, L. A. Hajjar, M. Lins, G. B. Nair, T. Whitehouse, J. Mariani, M. Latil, S. Camelo, R. Lafont, P. J. Dilda, S. Veillet, S. Agus

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.

Country	Count	As %
United States	1	20%
Unknown	4	80%

Type	Count	As %
Members of the public	4	80%
Scientists	1	20%

Mendeley readers

The data shown below were compiled from readership statistics for 415 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Country	Count	As %
Unknown	415	100%

Readers by professional status	Count	As %
Student > Bachelor	49	12%
Student > Master	41	10%
Other	26	6%
Researcher	26	6%
Student > Ph. D. Student	20	5%
Other	73	18%
Unknown	180	43%

Readers by discipline	Count	As %
Medicine and Dentistry	97	23%
Nursing and Health Professions	41	10%
Biochemistry, Genetics and Molecular Biology	11	3%
Pharmacology, Toxicology and Pharmaceutical Science	11	3%
Agricultural and Biological Sciences	10	2%
Other	51	12%
Unknown	194	47%

Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised…